Today: 20 May 2026
Brambles share price rises on buyback update as March dividend date nears
24 February 2026
1 min read

Brambles share price rises on buyback update as March dividend date nears

Sydney, Feb 24, 2026, 18:05 AEDT — Market shut its doors for the day.

  • Brambles Limited (ASX:BXB) picked up 1.3%, ending Tuesday at A$24.84.
  • New ASX filings revealed plans for more buybacks and the cancellation of 77,358 shares.
  • Focus shifts now to how quickly buybacks ramp up ahead of the March 11 ex-dividend date.

Brambles Limited finished up 1.3% at A$24.84 on Tuesday, with shares moving between A$24.31 and A$24.91. The pallet pooling company reported increased action on its on-market buyback.

This is significant—buybacks are among the rare levers visible daily to investors. Put simply, with an on-market buyback, a company steps in to buy its own stock right on the exchange, a process that gradually reduces the number of shares out there.

It comes as investors brace for the coming weeks of capital returns. As Brambles approaches its dividend cutoff, traders increasingly focus on the share price, weighing the yield and the backing from the buyback.

Brambles reported in its daily ASX filing that on Feb. 23, it repurchased 77,358 shares for A$1.89 million, paying between A$24.14 and A$24.54 per share. Prior to that, the company had already bought back 12,287,724 shares. There’s still headroom: Brambles can purchase up to another 124,334,223 shares under its current cap. The buyback program is set to continue through June 30.

The filing also lists 77,358 ordinary shares set for cancellation on Feb. 25, tied to an on-market buyback. The price: A$1.887 million, according to the document.

Brambles lodged an application to quote 307 ordinary shares issued through its performance share plan, priced at A$23.9856 apiece. It’s a minor issuance tied to an employee scheme.

During the half-year call, CEO Graham Chipchase pointed to a big draw for customers: “easier to do business with us.” CFO Joaquin Gil, responding to Rimor Equity Research’s Scott Ryall on capex and pallet balances, added, “cashflow performance is sustainable.” Brambles Corporate Site

Brambles, in its half-year update, tightened its FY26 sales revenue growth guidance to a 3%-4% range at constant currency, holding the line on its 8%-11% forecast for underlying profit and bumping up free cash flow estimates now to between US$950 million and US$1.1 billion. The company set its interim dividend at 23 U.S. cents per share, or 32.74 Australian cents, with shares going ex-dividend on March 11 and the payment scheduled for April 9.

The stock last traded at A$24.84, putting it roughly 8% under its 52-week peak of A$26.93, but still comfortably higher than its low point of A$19.06 for the year, Barchart data show.

Still, there’s only so much juice left in capital returns for now. Brambles has already pointed to demand headwinds and volume uncertainty. If softness crops up again, pallet turns could slip, sending repair and transport costs higher. And should the stock price stay above the buyback range, every dollar spent nets the company fewer shares.

Stock Market Today

  • BlackBerry Shares Fall 2.74%, Despite 16% Monthly Gain and Strong Earnings Outlook
    May 19, 2026, 7:15 PM EDT. BlackBerry (BB) stock closed at $6.21, down 2.74%, underperforming the S&P 500's 0.67% decline. Despite this, BB has outpaced the Computer and Technology sector with a 16% rise over the past month. The company expects a 50% year-over-year increase in earnings per share (EPS) to $0.03 for the upcoming quarter, with full-year EPS and revenue projected at $0.17 and $600.2 million, reflecting growth of over 6% and 9%, respectively. BlackBerry holds a Zacks Rank of #2 (Buy), indicating positive analyst sentiment, though it trades at a forward price-to-earnings ratio of 36.81, a premium to its industry average of 18.56. Investors will watch earnings and analyst revisions closely as indicators of near-term business trends.

Latest articles

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

20 May 2026
SELLAS Life Sciences shares rose 4.1% to $7.59 Tuesday after CEO Angelos Stergiou said its Phase 3 AML trial is two events from final analysis. The company reported $107.1 million in cash and a first-quarter net loss of $8.4 million. The REGAL trial’s main measure is overall survival. SELLAS remains blinded to results until the 80th event triggers data review.
Red Robin Shares Rise After Earnings Beat

Red Robin Shares Rise After Earnings Beat

20 May 2026
Red Robin shares surged 15.6% after hours to $4.45 Tuesday, following first-quarter revenue of $378.3 million that beat Wall Street estimates despite a 0.6% drop in comparable sales and a 1.6% decline in guest traffic. Net loss was $2.2 million, or 12 cents per share. The company reaffirmed its 2026 outlook and said refranchising talks are in final stages.
8×8 Jumps on Profit Beat as Margins Stay Under Pressure

8×8 Jumps on Profit Beat as Margins Stay Under Pressure

20 May 2026
8x8 shares rose 14.1% to $2.75 in after-hours trading after reporting fourth-quarter revenue of $185.2 million, up 5%, and adjusted diluted earnings of 11 cents a share. Usage-based revenue grew over 70% year-over-year, making up 23% of service revenue. The company posted GAAP net income of $0.1 million, compared to a $5.4 million loss a year earlier. Fiscal 2027 revenue is forecast at $727 million to $747 million.
Salesforce stock (CRM) steadies, but Wall Street trims targets again ahead of Feb. 25 results
Previous Story

Salesforce stock (CRM) steadies, but Wall Street trims targets again ahead of Feb. 25 results

National Grid share price ticks up as Ofgem flags AI data-centre power crunch
Next Story

National Grid share price ticks up as Ofgem flags AI data-centre power crunch

Go toTop